SensoDetect is a MedTech AI company. The SensoDetect BERA proprietary technology functions as a key diagnostic aid for health care professionals within psychiatric care. Our unique method helps increase the efficiency of both diagnosis and medical treatment, it reduces hospitalization costs, and ultimately, can more effectively improve the quality of life for those suffering from ADHD, autism or schizophrenia. Brainstem Evoked Response Audiometry (BERA) is fast, easy to use, and completely safe for patients.
Stock Market and Company Information: Sensodetect on Spotlight Stock Market
Kallelse till årsstämma 2022
Årsredovisning 2021 med revisioner
Kallelse till bolagsstämma 2021
Fullmakt till bolagsstämma 2021
Anmälningssedel TO1 2019/2020
Protokoll Bolagsstämma 2020-06-29